• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pharmacological aspects of galantamine for the treatment of Alzheimer's disease.

作者信息

Kim Jae Kwang, Park Sang Un

机构信息

Division of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon, 406-772, Korea.

Department of Crop Science, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon, 34134, Korea.

出版信息

EXCLI J. 2017 Jan 10;16:35-39. doi: 10.17179/excli2016-820. eCollection 2017.

DOI:10.17179/excli2016-820
PMID:28337117
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5318685/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4229/5318685/310d82996cb3/EXCLI-16-35-t-001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4229/5318685/310d82996cb3/EXCLI-16-35-t-001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4229/5318685/310d82996cb3/EXCLI-16-35-t-001.jpg

相似文献

1
Pharmacological aspects of galantamine for the treatment of Alzheimer's disease.加兰他敏治疗阿尔茨海默病的药理学方面
EXCLI J. 2017 Jan 10;16:35-39. doi: 10.17179/excli2016-820. eCollection 2017.
2
Galantamine: a pharmacoeconomic review of its use in Alzheimer's disease.加兰他敏：对其用于阿尔茨海默病的药物经济学综述
Pharmacoeconomics. 2002;20(13):919-42. doi: 10.2165/00019053-200220130-00005.
3
Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease.加兰他敏治疗血管性痴呆或伴有脑血管疾病的阿尔茨海默病患者的认知功能减退
CNS Drugs. 2003;17(12):905-14. doi: 10.2165/00023210-200317120-00004.
4
Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review.多奈哌齐、卡巴拉汀和加兰他敏治疗阿尔茨海默病的临床疗效及成本效益：一项快速系统评价
Health Technol Assess. 2001;5(1):1-137. doi: 10.3310/hta5010.
5
Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.用于治疗阿尔茨海默病的胆碱酯酶抑制剂：药理作用与临床疗效之间的关系。
Drugs Aging. 2004;21(7):453-78. doi: 10.2165/00002512-200421070-00004.
6
Galantamine for Alzheimer's disease.加兰他敏用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2001(1):CD001747. doi: 10.1002/14651858.CD001747.
7
Influence of galantamine on vasomotor reactivity in Alzheimer's disease and vascular dementia due to cerebral microangiopathy.加兰他敏对阿尔茨海默病及脑微血管病所致血管性痴呆患者血管运动反应性的影响。
Stroke. 2007 Dec;38(12):3186-92. doi: 10.1161/STROKEAHA.107.492033. Epub 2007 Oct 25.
8
Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group.加兰他敏治疗轻至中度阿尔茨海默病患者的疗效与安全性：多中心随机对照试验。加兰他敏国际-1研究组
BMJ. 2000 Dec 9;321(7274):1445-9. doi: 10.1136/bmj.321.7274.1445.
9
Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.加兰他敏与美金刚联合治疗阿尔茨海默病的原理。
J Clin Pharmacol. 2006 Jul;46(7 Suppl 1):17S-26S. doi: 10.1177/0091270006288735.
10
The effects of galantamine treatment on caregiver time in Alzheimer's disease.加兰他敏治疗对阿尔茨海默病患者照料者时间投入的影响。
Int J Geriatr Psychiatry. 2003 Oct;18(10):942-50. doi: 10.1002/gps.1000.

引用本文的文献

1
Nrf2/Bach1 signaling axis: A promising multifaceted therapeutic strategy for Alzheimer's disease.Nrf2/Bach1信号轴：一种针对阿尔茨海默病的颇具前景的多方面治疗策略。
Neurotherapeutics. 2025 Apr;22(3):e00586. doi: 10.1016/j.neurot.2025.e00586. Epub 2025 Apr 7.
2
Therapeutic Potential of Bioactive Compounds from Bercht. & J. Presl.柏氏翠雀花中生物活性化合物的治疗潜力
Nutrients. 2023 Jun 27;15(13):2912. doi: 10.3390/nu15132912.
3
miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer's Disease.miRNAs 和干细胞作为阿尔茨海默病有前途的诊断和治疗靶点。

本文引用的文献

1
Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer's disease: post-hoc analysis of a randomized placebo-controlled study.美金刚与加兰他敏联合使用对阿尔茨海默病患者死亡率及疗效结局的影响：一项随机安慰剂对照研究的事后分析
Alzheimers Res Ther. 2016 Nov 15;8(1):47. doi: 10.1186/s13195-016-0214-x.
2
Comprehensive effects of galantamine and cilostazol combination therapy on patients with Alzheimer's disease with asymptomatic lacunar infarction.加兰他敏与西洛他唑联合治疗对伴有无症状腔隙性脑梗死的阿尔茨海默病患者的综合影响。
Geriatr Gerontol Int. 2017 Oct;17(10):1384-1391. doi: 10.1111/ggi.12870. Epub 2016 Aug 31.
3
J Alzheimers Dis. 2023;94(s1):S203-S225. doi: 10.3233/JAD-221298.
4
Advances on Therapeutic Strategies for Alzheimer's Disease: From Medicinal Plant to Nanotechnology.阿尔茨海默病治疗策略的进展：从药用植物到纳米技术。
Molecules. 2022 Jul 28;27(15):4839. doi: 10.3390/molecules27154839.
5
Dietary Polyphenols as Therapeutic Intervention for Alzheimer's Disease: A Mechanistic Insight.膳食多酚作为阿尔茨海默病的治疗干预措施：机制洞察
Antioxidants (Basel). 2022 Mar 15;11(3):554. doi: 10.3390/antiox11030554.
6
Comprehensive Review on Alzheimer's Disease: Causes and Treatment.阿尔茨海默病的综合综述：病因与治疗。
Molecules. 2020 Dec 8;25(24):5789. doi: 10.3390/molecules25245789.
7
Spore powder of Ganoderma lucidum for the treatment of Alzheimer disease: A pilot study.灵芝孢子粉治疗阿尔茨海默病：一项初步研究。
Medicine (Baltimore). 2018 May;97(19):e0636. doi: 10.1097/MD.0000000000010636.
8
Role of Plant Derived Alkaloids and Their Mechanism in Neurodegenerative Disorders.植物源性生物碱在神经退行性疾病中的作用及其机制。
Int J Biol Sci. 2018 Mar 9;14(3):341-357. doi: 10.7150/ijbs.23247. eCollection 2018.
Efficacy of Galantamine on Cognition in Mild-to-Moderate Alzheimer's Dementia after Failure to Respond to Donepezil.
加兰他敏对多奈哌齐治疗无效的轻至中度阿尔茨海默病痴呆患者认知功能的疗效
Psychiatry Investig. 2016 May;13(3):341-8. doi: 10.4306/pi.2016.13.3.341. Epub 2016 May 18.
4
Ceria-containing uncoated and coated hydroxyapatite-based galantamine nanocomposites for formidable treatment of Alzheimer's disease in ovariectomized albino-rat model.含铈的未涂层和涂层羟基磷灰石基加兰他敏纳米复合材料用于去卵巢白化大鼠模型中阿尔茨海默病的有效治疗
Mater Sci Eng C Mater Biol Appl. 2016 Aug 1;65:151-63. doi: 10.1016/j.msec.2016.04.041. Epub 2016 Apr 14.
5
Pharmacological, toxicological and neuronal localization assessment of galantamine/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer's disease management.加兰他敏/壳聚糖复合纳米颗粒在大鼠体内的药理学、毒理学及神经元定位评估：对阿尔茨海默病治疗的未来潜在贡献
Drug Deliv. 2016 Oct;23(8):3111-3122. doi: 10.3109/10717544.2016.1153748. Epub 2016 Mar 4.
6
α4 nicotinic acetylcholine receptor modulated by galantamine on nigrostriatal terminals regulates dopamine receptor-mediated rotational behavior.加兰他敏调节黑质纹状体终末的α4烟碱型乙酰胆碱受体可调节多巴胺受体介导的旋转行为。
Neurochem Int. 2016 Mar;94:74-81. doi: 10.1016/j.neuint.2016.02.008. Epub 2016 Feb 18.
7
Effect of Donepezil, Tacrine, Galantamine and Rivastigmine on Acetylcholinesterase Inhibition in Dugesia tigrina.多奈哌齐、他克林、加兰他敏和卡巴拉汀对虎纹涡虫乙酰胆碱酯酶抑制作用的影响。
Molecules. 2016 Jan 11;21(1):53. doi: 10.3390/molecules21010053.
8
Galantamine attenuates amyloid-β deposition and astrocyte activation in APP/PS1 transgenic mice.加兰他敏可减轻APP/PS1转基因小鼠的淀粉样β蛋白沉积和星形胶质细胞活化。
Exp Gerontol. 2015 Dec;72:244-50. doi: 10.1016/j.exger.2015.10.015. Epub 2015 Oct 28.
9
Galantamine-loaded solid-lipid nanoparticles for enhanced brain delivery: preparation, characterization, in vitro and in vivo evaluations.载加兰他敏固体脂质纳米粒用于增强脑内递送：制备、表征、体外和体内评价
Drug Deliv. 2016 May;23(4):1434-43. doi: 10.3109/10717544.2015.1089956. Epub 2015 Sep 25.
10
Long-Term Efficacy of Galantamine in Alzheimer's Disease: The Okayama Galantamine Study (OGS).加兰他敏治疗阿尔茨海默病的长期疗效：冈山加兰他敏研究（OGS）。
J Alzheimers Dis. 2015;47(3):609-17. doi: 10.3233/JAD-150308.